Qiagen N.V. (ETR: QIA)
Germany
· Delayed Price · Currency is EUR
41.05
+0.83 (2.05%)
Nov 22, 2024, 5:35 PM CET
Qiagen Revenue
Qiagen had revenue of $501.87M USD in the quarter ending September 30, 2024, with 5.46% growth. This brings the company's revenue in the last twelve months to $1.97B, up 0.62% year-over-year. In the year 2023, Qiagen had annual revenue of $1.97B, down -8.23%.
Revenue (ttm)
$1.97B
Revenue Growth
+0.62%
P/S Ratio
n/a
Revenue / Employee
$355.48K
Employees
5,531
Market Cap
9.15B EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 1.97B | -176.21M | -8.23% |
Dec 31, 2022 | 2.14B | -110.14M | -4.89% |
Dec 31, 2021 | 2.25B | 381.31M | 20.39% |
Dec 31, 2020 | 1.87B | 343.92M | 22.53% |
Dec 31, 2019 | 1.53B | 24.58M | 1.64% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionQiagen News
- 16 days ago - Wellington Management Group LLP's Strategic Acquisition of Qiagen NV Shares - GuruFocus
- 17 days ago - Qiagen N.V. (QGEN) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 18 days ago - Diagnostics firm Qiagen reports rise in third-quarter revenue - Reuters
- 20 days ago - QIAGEN receives FDA clearance of QIAstat-Dx meningitis/encephalitis panel to support emergency diagnostics - GlobeNewsWire
- 26 days ago - QIAGEN receives FDA clearance for QIAstat-Dx mini panel to improve precision in outpatient respiratory treatment - GlobeNewsWire
- 6 weeks ago - QIAGEN expands automated liquid biopsy portfolio to enhance oncology, prenatal care and organ transplant applications - GlobeNewsWire
- 6 weeks ago - QIAGEN N.V. to release results for Q3 2024 and hold webcast - GlobeNewsWire
- 6 weeks ago - Global TB Summit 2024: QIAGEN leads the charge as tuberculosis reemerges as a leading infectious killer - GlobeNewsWire